Tyson Foods, Inc. TSN

NYSE · Consumer Defensive · Agricultural Farm Products

$65.12

Close on Fri, 20 Nov 2026 · market value $22.5B

What the price is betting on

Below its record

At $65, the price assumes revenue shrinks about 7.1% a year for five years, from $56.4B to about $39B by FY2031. That is about the same as what analysts expect for the next two years and less than the company's own last three years.

The price assumes−7.1%
Analysts, next two years−1.9%
Last 3 years2.2%

Revenue growth a year. The price figure comes from a reverse DCF at a 6.9% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than TSN? Check up to 5 of your stocks at once, free, no account.

0$20B$40B$60B$56.4B'23'24'25'26'27'28'29'30'31What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$87

Base

$98

Bull

$110

Today $65

  • Bear $87. Cash flow grows -2% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $98. Cash flow grows -0% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $110. Cash flow grows 2% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2027$52.4B$53.9B, on the path
  3. FY2028$48.7B$54.3B, on the path
  4. FY2029$45.2B$55.8B, on the path
  5. FY2030$42BNo estimate yet
  6. FY2031$39BThe full bet

Each year's revenue at −7.1% growth from $56.4B in FY2026.

At a glance

Consumer Defensive · Agricultural Farm Products · listed on NYSE

Revenue, FY2026
$56.4B
Growth, 3 years a year
2.2%
Cash margin
2.9%
Net debt
$6.9B
Shares, 3-year change
+25%
Dividend yield
3.1%

What other consumer defensive prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.